(Q37242234)

19 August 2017

A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity (English)

1 reference

19 August 2017

G Kéri

1 reference

19 August 2017

J Erchegyi

1 reference

19 August 2017

A Horváth

1 reference

19 August 2017

I Mezõ

1 reference

19 August 2017

M Idei

1 reference

19 August 2017

T Vántus

1 reference

19 August 2017

A Balogh

1 reference

19 August 2017

Z Vadász

1 reference

19 August 2017

G Bökönyi

1 reference

19 August 2017

J Seprõdi

1 reference

19 August 2017

I Teplán

1 reference

19 August 2017

O Csuka

1 reference

19 August 2017

M Tejeda

1 reference

19 August 2017

D Gaál

1 reference

19 August 2017

Z Szegedi

1 reference

19 August 2017

B Szende

1 reference

19 August 2017

C Roze

1 reference

19 August 2017

H Kalthoff

1 reference

19 August 2017

A Ullrich

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

Proceedings of the National Academy of Sciences of the United States of America

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

12513-12518

1 reference

Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

The 86-kDa subunit of autoantigen Ku is a somatostatin receptor regulating protein phosphatase-2A activity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Oncological applications of somatostatin analogues

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Synthesis and biological activity of highly potent octapeptide analogs of somatostatin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Regulation of ATP-sensitive K+ channels in insulinoma cells: activation by somatostatin and protein kinase C and the role of cAMP.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Tyrosine kinase inhibition: an approach to drug development

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

The somatostatin receptor family.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+ channels in the beta cell

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

The tumor-selective somatostatin analog, TT2-32 induces a biphasic activation of phosphotyrosine phosphatase activity in human colon tumor cell line, SW620

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Structure-activity relationship studies of novel somatostatin analogs with antitumor activity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Determination of subcutaneous tumor size in athymic (nude) mice

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Response of human lung tumor xenografts to treatment with a somatostatin analogue (Somatuline).

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

Novel antitumor peptide hormones and their effect on signal transduction

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

G protein activation of a hormone-stimulated phosphatase in human tumor cells.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38023

A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA

3 September 2018

1 reference

12 December 2020

Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity

1 reference

12 December 2020

Conformational study of a series of somatostatin analogues with antitumor and/or GH inhibitory activity

1 reference

12 December 2020

SMS 201-995 in the treatment of refractory prostatic carcinoma

1 reference

12 December 2020

Cell cycle dependent induction of apoptosis by somatostatin analog SMS 201-995 in AtT-20 mouse pituitary cells

1 reference

12 December 2020

Tyrphostin induces non-apoptotic programmed cell death in colon tumor cells

1 reference

12 December 2020

1 reference

12 December 2020

Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells

1 reference

12 December 2020

Comparison of the tyrosine kinase activity with the proliferation rate in human colon solid tumors and tumor cell lines

1 reference

12 December 2020

Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.93.22.12513

1 reference

19 August 2017

0 references

1 reference

19 August 2017

PubMed publication ID

8901613

1 reference